Appukuttan Murali, Kumar Senthil, Bharathy Kishore Gurumoorthy Subramanya, Pandey Vijay Kant, Pamecha Viniyendra
From the Department of Liver Transplantation and Hepato Pancreatico Biliary Surgery, Institute of Liver and Biliary Sciences, New Delhi, India.
Exp Clin Transplant. 2019 Feb;17(1):64-73. doi: 10.6002/ect.2017.0138. Epub 2018 Jan 22.
An optimal initial graft function after living-donor liver transplant depends on optimal graft hemodynamics. Nonmechanical impediments to free hepatic venous outflow, due to elevated central venous pressure, may obstruct the "functional" hepatic venous outflow. Here, we evaluated whether central venous pressure affected early graft function and outcomes in adult living-donor liver transplant recipients.
This prospective observational study included 61 living-donor liver transplant recipients without technical complications who received transplants from August 2013 to November 2014. Hemodynamic variables were measured preoperatively, at anhepatic phase, 30 minutes postreperfusion, at end of surgery, and during postoperative days 1-5.
Patients with high central venous pressure showed functional hepatic venous outflow obstruction, which caused delayed recovery of graft function. Although postoperative central venous pressure was the only identified independent risk factor for mortality, all 5 deaths in our study group occurred in those who had high central venous pressure at the anhepatic, postreperfusion, end of surgery, and postoperative phases. A postoperative central venous pressure value of ~11 mm Hg was determined to be the cutoff for high-risk mortality, with area under the curve of 0.859 (sensitivity of 80%, specificity of 68%). Increased central venous pressure was associated with increased portal venous pressure (increase of 45%, range, 28%-89%; P = .001). Central venous pressure at end of surgery (r = 0.45, P ≤ .001) and at posttransplant time points (r = 0.29, P = .02) correlated well with portal venous pressure at end of surgery. Other risk factors for early allograft dysfunction were Model for End-Stage Liver Disease and cardiac output posttransplant.
High central venous pressure, modulating portal venous pressure, can result in functional hepatic venous outflow obstruction, causing delayed graft function recovery and increased risk of mortality. Maintaining a central venous pressure below 11 mm Hg is beneficial.
活体肝移植术后的最佳初始移植肝功能取决于最佳的移植肝血流动力学。由于中心静脉压升高导致的肝静脉自由流出的非机械性阻碍,可能会阻碍“功能性”肝静脉流出。在此,我们评估了中心静脉压是否会影响成人活体肝移植受者的早期移植肝功能和预后。
这项前瞻性观察性研究纳入了2013年8月至2014年11月期间接受移植且无技术并发症的61例活体肝移植受者。在术前、无肝期、再灌注后30分钟、手术结束时以及术后第1 - 5天测量血流动力学变量。
中心静脉压高的患者出现功能性肝静脉流出道梗阻,导致移植肝功能恢复延迟。尽管术后中心静脉压是唯一确定的独立死亡危险因素,但我们研究组的5例死亡均发生在无肝期、再灌注后、手术结束时及术后阶段中心静脉压高的患者中。术后中心静脉压值约11 mmHg被确定为高风险死亡的临界值,曲线下面积为0.859(敏感性80%,特异性68%)。中心静脉压升高与门静脉压力升高相关(升高45%,范围28% - 89%;P = 0.001)。手术结束时的中心静脉压(r = 0.45,P≤0.001)和移植后各时间点的中心静脉压(r = 0.29,P = 0.02)与手术结束时的门静脉压力相关性良好。早期移植肝功能障碍的其他危险因素包括终末期肝病模型和移植后心输出量。
高中心静脉压通过调节门静脉压力,可导致功能性肝静脉流出道梗阻,引起移植肝功能恢复延迟和死亡风险增加。将中心静脉压维持在11 mmHg以下是有益的。